Program:
The era of molecular diagnostics in cancer is approaching. In order to prevent cancer, we need to understand the disease on a molecular basis and diagnose it early. This will be accomplished through the creation of a cancer gene index, which will categorize the multitude of genes associated with cancer. Libraries of cDNA expression in cancer are being constructed, and high speed technologies will track molecular processes in a cancer cell. Rather than characterizing cancer on the basis of the tissue of origin and the appearance of cells biopsied, it will be possible with the new techniques being developed to detect precancerous growths and make a molecular diagnosis on which an effective treatment will be made. The overall direction of the National Cancer Institute, an overview of gene-based diagnostics, the profiling of cancer genes, and the newest gene-based therapeutic drugs will be discussed.
Keynote Presentation: Dr. Richard Klausner, National Cancer Institute
Program Sessions
* Genetics of Cancer Overview
* Analyzing Gene Expression in Cancer
* Gene-Based Diagnostics
* Gene-Based Therapeutics
Registration :
Cambridge Healthtech Institute, 1037 Chestnut Street,
Newton Upper Falls, MA 02164
Tel: 617 630 1300 Fax: 617 630 1325
email: chi@healthtech.com
http://www.healthtech.com/conferences/
Deadline for Abstracts: August 29, 1997
Email for Requests and Registration: chi@healthtech.com